Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours

Danish Medical Bulletin

Volumn 53, Issue 3, 2006, Pages 326-341

  Schmiegelow, Marianne ^a,b  

^a Mental Health Services CPH   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FOLLITROPIN; GONADOTROPIN; GROWTH HORMONE; INHIBIN B; LOMUSTINE; METHOTREXATE; PROCARBAZINE; PROLACTIN; THYROID HORMONE; THYROTROPIN; VINCRISTINE;

ASTROCYTOMA; AZOOSPERMIA; BRAIN CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CORTICOTROPIN DEFICIENCY; DENMARK; DOSIMETRY; ENDOCRINE DISEASE; EPENDYMOMA; GERM CELL TUMOR; GLIOMA; GONAD DYSFUNCTION; GROWTH HORMONE DEFICIENCY; HEMANGIOPERICYTOMA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; MEDULLOBLASTOMA; METHODOLOGY; NEUROECTODERM TUMOR; NEUROSURGERY; OLIGOSPERMIA; PINEAL BODY TUMOR; PRECOCIOUS PUBERTY; RADIATION DOSE FRACTIONATION; REVIEW; SCANDINAVIA; THYROID DISEASE;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOCRINE SYSTEM DISEASES; FEMALE; GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; HYPOTHYROIDISM; INHIBINS; MALE; MEDULLOBLASTOMA; RADIOTHERAPY DOSAGE; TESTICULAR NEOPLASMS; THYROID GLAND; THYROTROPIN; TIME FACTORS;

EID: 33747689876     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Aarimaa, T, Arola, M., and Salmi, T.T. (1997). CNS tumours in south-western Finland: high location, high incidence. Acta Paediatr 86, 1074-1076.
2. Abdu, T.A., Elhadd, T.A., Neary, R., and Clayton, R.N. (1999). Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 84, 838-843.
3. Achermann, J.C., Hindmarsh, P.C., and Brook, C.G. (1998). The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours. Clin Endocrinol (Oxf) 49, 639-645.
4. Ahmed, S.R. and Shalet, S.M. (1984). Hypothalamic growth hormone releasing factor deficiency following cranial irradiation. Clin.Endocrinol.Oxf. 21, 483-488.
5. Ahmed, S.R., Shalet, S.M., Campbell, R.H., and Deakin, D.P (1983). Primary gonadal damage following treatment of brain tumors in childhood. J.Pediatr. 103, 562-565.
6. Alba-Roth, J., Muller, O.A., Schopohl, J., and von Werder, K. (1988). Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67, 1186-1189.
7. Ammari, F., Issa, B.G., Millward, E., and Scanion, M.F. (1996). A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function. Clin Endocrinol (Oxf) 44, 473-476.
8. Anawalt, B.D., Bebb, R.A., Matsumoto, A.M., Groome, N.P, Illingworth, P.J., McNeilly, A.S., and Bremner, W.J. (1996). Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 81, 3341-3345.
9. Andersen, E. (1982). Height and weigth in Danish children. Ugeskr.Laeger 144, 1760-1765.
10. Andersen, P.B., Krabbe, K., Leffers, A.M., Schmiegelow, M., Holm, S., Laursen, H., Muller, J.R., and Paulson, O.B. (2003). Cerebral glucose metabolism in long-term survivors of childhood primary brain tumors treated with surgery and radiotherapy. J Neurooncol 62, 305-313.
11. Andersson, A.M., Muller, J., and Skakkebaek, N.E. (1998). Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab 83, 4451-4458.
12. Andersson, A.M., Orskov, H., Ranke, M.B., Shalet, S., and Skakkebaek, N.E. (1995). Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. Eur.J Endocrinol. 132, 340-343.
13. Arnold, A. (1953). Effects of X-Irradiation on the Hypothalamus. Journal of Clinical Endocrinology and Metabolism 14, 859-868.
14. Bailey, C. C., Gnekow, A, Wellek, S, Jones, M., Round, C, Brown, J, Philips, A, and Neidhardt, MKProspective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Medical and Pediatric Oncology 25:166-178 (1995).
15. Bangar, V. and Clayton, R.N. (1998). How reliable is the short synacthen test for the investigation of the hypothalamic-pituitary-adrenal axis? Eur J Endocrinol JID-9423848 139, 580-583.
16. Barendsen, G.W. (1982). Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int.J.Radiat.Oncol.Biol.Phys. 8, 1981-1997.
17. Bentel, G.C. (1996). Radiation therapy planning : including problems and solutions, 2. ed edition. McGraw-Hill, New York.
18. Bessho, F., Ohta, K., Akanuma, A., and Sakata, K. (1994). Dosimetry of radiation scattered to thyroid gland from prophylactic cranial irradiation for childhood leukemia. Pediatr.Hematol.Oncol. 11, 47-53.
19. Bleyer, W.A. (1990a). The impact of childhood cancer on the United States and the world. CA.Cancer J Clin. 40, 355-367.
20. Bleyer, W.A. (1999b). Epidemiologic impact of children with brain tumors. Childs Nerv Syst 15, 758-763.
21. Boquete, H.R., Sobrado, PG., Fideleff, H.L., Sequera, A.M., Giaccio, A.V., Suarez, M.G., Ruibal, G.F., and Miras, M. (2003). Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. J Clin Endocrinol Metab 88, 4702-4708.
22. Boulad, F., Bromley, M., Black, P., Heller, G., Sarafoglou, K., Gillio, A., Papadopoulos, E., and Sklar, C. (1995). Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant. 15, 71-76.
23. Bramswig, J.H., Heimes, U., Heiermann, E., Schlegel, W., Nieschlag, E., and Schellong, G. (1990). The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 65, 1298-1302.
24. Brauner, R., Rappaport, R., Prevot, C., Czernichow, P., Zucker, J.M., Bataini, P., Lemerle, J., Sarrazin, D., and Guyda, H.J. (1989). A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J.Clin.Endocrinol.Metab. 68, 346-351.
25. Brennan, B.M., Rahim, A., Mackie, E.M., Eden, O.B., and Shalet, S.M. (1998). Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol Oxf. 48, 777-783.
26. Burke, C.W. (1992). The pituitary megatest: outdated? Clin Endocrinol (Oxf) 36, 133-134.
27. Casarett, G. (1972). Frontiers of radiation therapy and oncology (Vaeth, J., Ed.) Karger,S, New York. 479-485.
28. Chapman, R.M., Sutcliffe, S.B., Rees, L.H., Edwards, C.R., and Malpas, J.S. (1979). Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet 1, 285-289.
29. Charak, B.S., Gupta, R., Mandrekar, P., Sheth, N.A., Banavali, S.D., Saikia, T.K., Gopal, R., Dinshaw, K.A., and Advani, S.H. (1990). Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study. Cancer 65, 1903-1906.
30. Chen, G.T., Pelizzari, C.A., Spelbring, D.R., and Awan, A. (1987). Evaluation of treatment plans using dose volume histograms. Front Radiat Ther Oncol 21, 44-55.
31. Chin, D., Sklar, C., Donahue, B., Uli, N., Geneiser, N., Allen, J., Nirenberg, A., David, R., Kohn, B., and Oberfield, S.E. (1997). Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/ primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 80, 798-804.
32. Clayton, P.E. and Shalet, S.M. (1991). Dose dependency of time of onset of radiation-induced growth hormone deficiency. J.Pediatr. 118, 226-228.
33. Clayton, P.E., Shalet, S.M., Price, D.A., and Campbell, R.H. (1988). Testicular damage after chemotherapy for childhood brain tumors. J.Pediatr. 112, 922-926.
34. Clayton, R.N. (1996). Short Synacthen test versus insulin stress test for assessment of the hypothalamo [correction of hypothalmo]-pituitary-adrenal axis: controversy revisited. Clin Endocrinol (Oxf) 44, 147-149.
35. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society (2000). J Clin Endocrinol Metab 85, 3990-3993.
36. Constine, L.S., Donaldson, S.S., McDougall, I.R., Cox, R.S., Link, M.P., and Kaplan, H.S. (1984). Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 53, 878-883.
37. Constine, L.S., Rubin, P., Woolf, P.D., Doane, K., and Lush, C.M. (1987). Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J Clin.Oncol 5, 841-1851.
38. Constine, L.S., Woolf, P.D., Cann, D., Mick, G., McCormick, K., Raubertas, R.F., and Rubin, P. (1993). Hypothalamic-pituitary dysfunction after radiation for brain tumors [published erratum appears in N Engl J Med 1993 Apr 22; 328(16):1208] [see comments]. N.Engl.J.Med. 328, 87-94.
39. Coutard, HPrinciples of X ray therapy of malignant diseases. Lancet 7:5784-5794 (1934).
40. Darendeliler, F., Livesey, E.A., Hindmarsh, P.C., and Brook, C.G. (1990). Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy. Acta Paediatr.Scand. 79, 950-956.
41. Darzy, K.H., Aimaretti, G., Wieringa, G., Gattamaneni, H.R., Ghigo, E., and Shalet, S.M. (2003). The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 88, 95-102.
42. de Nully Brown, P., Olsen, J.H., Hertz, H., Carstensen, B., and Bautz, A. (1995). Trends in survival after childhood cancer in Denmark, 1943-87: a population-based study. Acta Paediatr. 84, 316-324.
43. Dickstein, G., Shechner, C., Nicholson, W.E., Rosner, I., Shen-Orr, Z., Adawi, F., and Lahav, M. (1991). Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 72, 773-778.
44. Duffner, P.K. and Cohen, M.E. (1991). The long-term effects of central nervous system therapy on children with brain tumors. Neurol.Clin. 9, 479-495.
45. Duffner, P.K. and Cohen, M.E. (1991). Long-term consequences of CNS treatment for childhood cancer, Part II: Clinical consequences. Pediatr. Neurol. 7, 237-242.
46. Duffner, P.K., Cohen, M.E., Thomas, P.R., and Lansky, S.B. (1985b). The long-term effects of cranial irradiation on the central nervous system. Cancer 56, 1841-1846.
47. Duffner, P.K., Cohen, M.E., Voorhess, M.L., MacGillivray, M.H., Brecher, M.L., Panahon, A., and Gilani, B.B. (1985a). Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer 56, 2189-2193.
48. Ellis, F. (1969). Dose, time and fractionation: a clinical hypothesis. Clin Radiol 20, 1-7.
49. Erturk, E., Jaffe, C.A., and Barkan, A.L. (1998). Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J.Clin.Endocrinol.Metab. 83, 2350-2354.
50. Evans, A.E., Jenkin, R.D., Sposto, R., Ortega, J.A., Wilson, C.B., Wara, W., Ertel, I.J., Kramer, S., Chang, C.H., and Leikin, S.L. (1990). The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72, 572-582.
51. Faglia, G. (1998). The clinical impact of the thyrotropin-releasing hormone test. Thyroid 8, 903-908.
52. Faglia, G., Bitensky, L., Pinchera, A., Ferrari, C., Paracchi, A., Beck-Peccoz, P., Ambrosi, B., and Spada, A. (1979). Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 48, 989-998.
53. Fowler, J.F. (1989). The linear-quadratic formula and progress in fractionated radiotherapy. The British Journal of Radiology 62, 679-694.
54. Fowler, J.F. (1992). Modelling altered fractionation schedules. BJR.Suppl. 24, 187-192.
55. Furlanetto, R.W., Underwood, L.E., Van Wyk, J.J., and D'Ercole, A.J. (1977). Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60, 648-657.
56. Ghigo, E., Bellone, J., Aimaretti, G., Bellone, S., Loche, S., Cappa, M., Bartolotta, E., Dammacco, F., and Camanni, F. (1996). Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin.Endocrinol.Metab. 81, 3323-3327.
57. Ghigo, E., Bellone, J., Mazza, E., Imperiale, E., Procopio, M., Valente, F., Lala, R., De Sanctis, C., and Camanni, F. (1990). Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol (Oxf) 32, 763-767.
58. Gill, M.S., Toogood, A.A., O'Neill, P.A., Thorner, M.O., Shalet, S.M., and Clayton, P.E. (1998). Urinary growth hormone (GH), insulin-like growth factor I (IGF-I), and IGF-binding protein-3 measurements in the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 83, 2562-2565.
59. Gjerris, F., Agerlin, N., Borgesen, S. E., Buhl, L., Haase, J., Klinken, L., Mortensen, A. C., Olsen, J. H., Ovesen, N., Reske-Nielsen, E., and Schmidt, K. Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960-1984. Childs Nerv Syst 14:302-311 (1998).
60. Gleeson, H.K., Walker, B.R., Seckl, J.R., and Padfield, P.L. (2003). Ten years on: Safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. J Clin Endocrinol Metab 88, 2106-2111.
61. Goitein, M. (1985). Future prospects in planning radiation therapy. Cancer 55, 2234-2239.
62. Goitein, M. and Abrams, M. (1983). Multi-dimensional treatment planning: I. Delineation of anatomy. Int J Radiat Oncol Biol Phys 9, 777-787.
63. Groome, N.P., Illingworth, P.J., O'Brien, M., Pai, R., Rodger, F.E., Mather, J.P., and McNeilly, A.S. (1996). Measurement of dimeric inhibin B throughout the human menstrual cycle. J.Clin.Endocrinol.Metab. 81, 1401-1405.
64. Growth Hormone Research Society (1998). Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin.Endocrinol.Metab. 83, 379-381.
65. Hancock, S.L., McDougall, I.R., and Constine, L.S. (1995). Thyroid abnormalities after therapeutic external radiation. Int.J.Radiat.Oncol.Biol.Phys. 31, 1165-1170.
66. Hartoft-Nielsen, M.L., Lange, M., Rasmussen, A.K., Scherer, S., Zimmermann-Belsing, T., and Feldt-Rasmussen, U. (2004). Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm Res 61, 53-57.
67. Hilding, A., Hall, K., Wivall-Helleryd, I.L., Saaf, M., Melin, A.L., and Thoren, M. (1999). Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84, 2013-2019.
68. Hjalmars, U., Kulldorff, M., Wahlqvist, Y., and Lannering, B. (1999). Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors. Cancer 85, 2077-2090.
69. Howell, S.J., Radford, J.A., Ryder, W.D., and Shalet, S.M. (1999). Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol 17, 1493-1498.
70. Hurel, S.J., Thompson, C.J., Watson, M.J., Harris, M.M., Baylis, P.H., and Kendall-Taylor, P. (1996). The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 44, 141-146.
71. Illingworth, P.J., Groome, N.P., Byrd, W., Rainey, W.E., McNeilly, A.S., Mather, J.P., and Bremner, W.J. (1996). Inhibin-B: a likely candidate for the physiologically important form of inhibin in men [see comments]. J Clin Endocrinol Metab 81, 1321-1325.
72. Ilveskoski, I.; Pihko,H.; Wiklund,T.; Lamminranta,S.; Perkkiö,M.; Mäkipernaa,A.; Salmi,T.T. (1996) Neuropsychologic late effects in children with malignant brain tumors treated with surgery, radiotherapy and "8 in 1" chemotherapy. Neuropediatrics 27, 124-129.
73. Joiner, M.C. (1999). Basic Clinical Radiobiology (Steel, G.G., Ed.) Second Edition edition. Edward Arnold Publishers, London. 173-183.
74. Joiner, M.C. and Van der Kogel, A.J. (1999). Basic Clinical Radiobiology (Steel, G.G., Ed.) Second edition. Edward Arnold Publishers, London. 106-121.
75. Jones, S.L., Trainer, P.J., Perry, L., Wass, J.A., Bessser, G.M., and Grossman, A. (1994). An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 41, 123-128.
76. Juul, A., Bang, P., Hertel, N.T., Main, K., Dalgaard, P., Jorgensen, K., Müller, J., Hall, K., and Skakkebaek, N.E. (1994). Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J.Clin.Endocrinol. Metab. 78, 744-752.
77. Juul, A., Dalgaard, P., Blum, W.F., Bang, P., Hall, K., Michaelsen, K.F., Müller, J., and Skakkebaek, N.E. (1995). Serum levels of insulin-like growth factor (IGF)-binding protein- 3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J.Clin.Endocrinol.Metab. 80, 2534-2542.
78. Juul, A., Moller, S., Mosfeldt-Laursen, E., Rasmussen, M.H., Scheike, T., Pedersen, S.A., Kastrup, K.W., Yu, H., Mistry, J., Rasmussen, S., Muller, J., Henriksen, J., and Skakkebaek, N.E. (1998). The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J Clin Endocrinol Metab 83, 4408-4415.
79. Juul, A. and Skakkebaek, N.E. (1997). Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J.Pediatr. 130, 197-204.
80. Juul, J The protracted fractional roentgen treatment of malignant tumors ad modum Coutard. Acta Radiol. XVII:209-234 (1936).
81. Kaplan, M.M., Garnick, M.B., Gelber, R., Li, F.P., Cassady, J.R., Sallan, S.E., Fine, W.E., and Sack, M.J. (1983). Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 74, 272-280.
82. Kelly, K.H., Feldsted, E.T., and Brown, R.F. (1951). Irradiation of normal human hypophysis in malignancy: report of three cases receiving 8100-10000 r tissue dose to the pituitary gland. Journal of National Cancer Institute 11, 967-973.
83. Kernohan, J.W. and Sayre, P.G. (1952). Atlas of Tumor Pathology (Anonymous). Washington, DC: Armed Forces Institute of Pathology. 17-18.
84. Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993). The new WHO classification of brain tumours. Brain Pathol. 3, 255-268.
85. Kortmann, R.D., Timmmermann, B., Becker, G., Kuhl, J., and Bamberg, M. (1998). Advances in treatment techniques and time/dose schedules in external radiation therapy of brain tumours in childhood. Klin Padiatr 210, 220-226.
86. Lam, K.S., Wang, C., Yeung, R.T., Ma, J.T., Ho, J.H., Tse, V.K., and Ling, N. (1986). Hypothalamic hypopituitarism following cranial irradiation for nasopharyngeal carcinoma. Clin.Endocrinol.Oxf. 24, 643-651.
87. Lange, M., Svendsen, O.L., Skakkebaek, N.E., Muller, J., Juul, A., Schmiegelow, M., and Feldt-Rasmussen, U. (2002). An audit of the insulin-tolerance test in 255 patients with pituitary disease. Eur J Endocrinol 147, 41-47.
88. Lannering, B. and Albertsson Wikland, K. (1987). Growth hormone release in children after cranial irradiation. Horm.Res. 27, 13-22.
89. Lannering, B. Marky, I., Lundberg, A., Olsson, E. (1990). Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med.Pediatr.Oncol. 18, 304-310.
90. Larkins, R.G. and Martin, F.I. (1973). Hypopituitarism after extracranial irradiation: evidence for hypothalamic origin. Br Med J 1, 152-153.
91. Leiper, A.D. (1995). Late effects of total body irradiation. Arch Dis Child-0372434 72, 382-385.
92. Leiper, A.D., Stanhope, R., Kitching, P., and Chessells, J.M. (1987). Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch.Dis.Child 62, 1107-1112.
93. Lentz, R.D., Bergstein, J., Steffes, M.W., Brown, D.R., Prem, K., Michael, A.F., and Vernier, R.L. (1977). Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty. J Pediatr 91, 385-394.
94. Lindholm, J. and Kehlet, H. (1987). Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol (Oxf) 26, 53-59.
95. Lindholm, J., Kehlet, H., Blichert-Toft, M., Dinesen, B., and Rüshede, J. (1978). Reliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 47, 272-274.
96. Littley, M.D., Shalet, S.M., Beardwell, C.G., Robinson, E.L., and Sutton, M.L. (1989). Radiation-induced hypopituitarism is dose-dependent. Clin.Endocrinol. Oxf. 31, 363-373.
97. Livesey, E.A. and Brook, C.G. (1989). Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch.Dis.Child 64, 593-595.
98. Livesey, E.A., Hindmarsh, P.C., Brook, C.G., Whitton, A.C., Bloom, H.J., Tobias, J.S., Godlee, J.N., and Britton, J. (1990). Endocrine disorders following treatment of childhood brain tumours. Br.J Cancer 61, 622-625.
99. Lustig, R.H., Schriock, E.A., Kaplan, S.L., and Grumbach, M.M. (1985). Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency. Pediatrics 76, 274-279.
100. Mackie, E.J., Radford, M., and Shalet, S.M. (1996). Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27, 74-78.
101. Marzullo, P., Di Somma, C., Pratt, K.L., Khosravi, J., Diamandis, A., Lombardi, G., Colao, A., and Rosenfeld, R.G. (2001). Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 86, 3001-3008.
102. Mayenknecht, J., Diederich, S., Bahr, V., Plockinger, U., and Oelkers, W. (1998). Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 83, 1558-1562.
103. Nishiyama, K., Tanaka, E., Tarui, Y., Miyauchi, K., and Okagawa, K. (1996). A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys 34, 439-444.
104. Oberfield, S.E., Allen, J.C., Pollack, J., New, M.I., and Levine, L.S. (1986). Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 108, 219-223.
105. Oberfield, S.E., Nirenberg, A., Allen, J.C., Cohen, H., Donahue, B., Prasad, V., Schiff, R., Pang, S., Ghavimi, F., David, R., Chrousos, G., and Sklar, C. (1997). Hypothalamic-pituitary-adrenal function following cranial irradiation. Horm.Res 47, 9-16.
106. Oberfield, S.E., Soranno, D., Nirenberg, A., Heller, G., Allen, J.C., David, R., Levine, L.S., and Sklar, C.A. (1996). Age at onset of puberty following high-dose central nervous system radiation therapy. Arch.Pediatr.Adolesc.Med. 150, 589-592.
107. Ogilvy Stuart, A.L., Clark, D.J., Wallace, W.H., Gibson, B.E., Stevens, R.F., Shalet, S.M., and Donaldson, M.D. (1992). Endocrine deficit after fractionated total body irradiation. Arch.Dis.Child 67, 1107-1110.
108. Ogilvy Stuart, A.L., Clayton, P.E., and Shalet, S.M. (1994). Cranial irradiation and early puberty. J.Clin.Endocrinol.Metab. 78, 1282-1286.
109. Ogilvy Stuart, A.L. and Shafer, S.M. (1995). Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch.Dis.Child 73, 141-146.
110. Ogilvy Stuart, A.L., Shalet, S.M., and Gattamaneni, H.R. (1991). Thyroid function after treatment of brain tumors in children. J.Pediatr. 119, 733-737.
111. Olshan, J.S., Gubernick, J., Packer, R.J., D'Angio, G.J., Goldwein, J.W., Willi, S.M., and Moshang, T.J. (1992). The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70, 2013-2017.
112. Paulino, A.C. (2002). Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 53, 543-547.
113. Pierik, F.H., Vreeburg, J.T., Stijnen, T., De Jong, F.H., and Weber, R.F. (1998). Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 83, 3110-3114.
114. Pryzant, R.M., Meistrich, M.L., Wilson, G., Brown, B., and McLaughlin, P. (1993). Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas. J Clin Oncol 11, 239-247.
115. Quigley, C., Cowell, C., Jimenez, M., Burger, H., Kirk, J., Bergin, M., Stevens, M., Simpson, J., and Silink, M. (1989). Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med 321, 143-151.
116. Ranke, M.B. and Haber, P. (1996). Diagnostics of Endocrine Function in Children and Adolescents (Ranke, M.B., Ed.) 2nd revised and expanded edition edition. Johann Ambrosius Barth Verlag (Edition J & J), Hüthig GmbH, Heidelberg. Leipzig, Heideberg. Leipzig. 134-148.
117. Rappaport, R., Brauner, R., Czernichow, P., Thibaud, E., Renier, D., Zucker, J.M., and Lemerle, J. (1982). Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin.Endocrinol.Metab. 54, 1164-1168.
118. Reimers, T.S., Ehrenfels, S., Mortensen, E.L., Schmiegelow, M., Sonderkaer, S., Carstensen, H., Schmiegelow, K., Muller, J. (2003). Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med.Pediatr.Oncol 40 (1), 26-34.
119. Reiter, E.O. and Rosenfeld, R.G. (2003). Williams Textbook of Endocrinology (Larsen, P.R., Kronenberg, H.M., Melmed, S., and Polonsky, K.S., Eds.) Tenth edition. Saunders, 1003-1114.
120. Ricardi, U., Corrias, A., Einaudi, S., Genitori, L., Sandri, A., di Montezemolo, L.C., Besenzon, L., Madon, E., and Urgesi, A. (2001). Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 50, 1287-1294.
121. Rogers, P.C., Fryer, C.J., and Hussein, S. (1982). Radiation dose to the thyroid in the treatment of acute lymphoblastic leukemia (ALL). Med. Pediatr. Oncol 10, 385-388.
122. Rorke, L.B.; Gilles, F.H.; Davis, R.L.; Becker, L.E. (1985). Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56(7), 1869-1886.
123. Samaan, N.A., Schultz, P.N., Yang, K.P., Vassilopoulou, S.R., Maor, M.H., Cangir, A., and Goepfert, H. (1987). Endocrine complications after radiotherapy for tumors of the head and neck. J Lab.Clin.Med. 109, 364-372.
124. Schimpff, S.C., Diggs, C.H., Wiswell, J.G., Salvatore, P.C., and Wiernik, P.H. (1980). Radiation-related thyroid dysfunction: implications for the treatment of Hodgkin's disease. Ann Intern Med. 92, 91-98.
125. Schmiegelow, M., Feldt-Rasmussen, U., Rasmussen, A.K., Lange, M., Poulsen, H.S., and Muller, J. (2003). Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 88, 3149-3154.
126. Schmiegelow, M., Feldt-Rasmussen, U., Rasmussen, A.K., Poulsen, H.S., and Muller, J. (2003). A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 88, 136-140.
127. Schmiegelow, M., Hansen, M.M., and Nielsen, N.C. (1995). Kvaliteten af kryopræserveret ejakulat ved Morbus Hodgkin. Ugeskr.Læger 157, 1501-1504.
128. Schmiegelow, M., Lassen, S., Poulsen, H.S., Feldt-Rasmussen, U., Schmiegelow, K., Hertz, H., and Muller, J. (2000). Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin Endocrinol (Oxf) 53, 191-197.
129. Schmiegelow, M., Lassen, S., Poulsen, H.S., Feldt-Rasmussen, U., Schmiegelow, K., Hertz, H., and Muller, J. (2000). Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors. Horm Res 54, 53-59.
130. Schmiegelow, M., Lassen, S., Poulsen, H.S., Schmiegelow, K., Hertz, H., Andersson, A.M., Skakkebaek, N.E., and Muller, J. (2001). Gonadal status in male survivors following childhood brain tumors. [published erratum appears in Journal of Clinical Endocrinology and Metabolism. 86(8): 3967. 2001]. J Clin Endocrinol Metab 86, 2446-2452.
131. Schmiegelow, M., Lassen, S., Weber, L., Poulsen, H.S., Hertz, H., and Muller, J. (1999). Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors. Med Pediatr Oncol 33, 564-571.
132. Sehested, A., Juul, A.A., Andersson, A.M., Petersen, J.H., Jensen, T.K., Muller, J., and Skakkebaek, N.E. (2000). Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 85, 1634-1640.
133. Shah, A., Stanhope, R., and Matthew, D. (1992). Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 304, 173-174.
134. Shalet, S.M., Beardwell, C.G., Aarons, B.M., Pearson, D., and Morris Jones, P.H. (1978). Growth impairment in children treated for brain tumours. Archives of Disease in Childhood 53, 491-494.
135. Shalet, S.M., Beardwell, C.G., Pearson, D., and Morris Jones, P.H. (1976). The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clinical Endocrinology 5, 287-290.
136. Shalet, S.M., Price, D.A., Beardwell, C.G., Jones, P.H., and Pearson, D. (1979). Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J Pediatr 94, 719-722.
137. Shalet, S.M., Rosenstock, J.D., Beardwell, C.G., Pearson, D., and Jones, P.H. (1977). Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood. Clin Radiol 28, 511-515.
138. Shankar, R.R., Jakacki, R.I., Haider, A., Lee, M.W., and Pescovitz, O.H. (1997). Testing the hypothalamic-pituitary-adrenal axis in survivors of childhood brain and skull-based tumors. J Clin Endocrinol Metab 82, 1995-1998.
139. Sklar, C., Sarafoglou, K., and Whittam, E. (1993). Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol.Copenh. 129, 511-515.
140. Sklar, C.A., Kim, T.H., and Ramsay, N.K. (1982). Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 73, 688-694.
141. Slater, J.D., Austin-Seymour, M., Munzenrider, J., Birnbaum, S., Carroll, R., Klibanski, A., Riskind, P., Urie, M., Verhey, L., and Goitein, M. (1988). Endocrine function following high dose proton therapy for tumors of the upper clivus. Int J Radiat Oncol Biol Phys 15, 607-611.
142. Smitt, M.C., McPeak, E.M., and Donaldson, S.S. (1998). The advantages of three-dimensional conformal radiotherapy for treatment of childhood cancer. Radiat Res 150, S170-S177
143. Sonderkaer, S., Schmiegelow, M., Carstensen, H., Nielsen, L.B., Muller, J., and Schmiegelow, K. (2003). Long-Term Neurological Outcome of Childhood Brain Tumors Treated by Surgery Only. J Clin Oncol 21, 1347-1351.
144. Spencer, C.A., Schwarzbein, D., Guttler, R.B., LoPresti, J.S., and Nicoloff, J.T. (1993). Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 76, 494-498.
145. Spitz, S. (1948). The histological effects of nitrogen mustards on human tumors ansd tissues. Cancer 383-398.
146. Spoudeas, H.A., Charmandari, E., and Brook, C.G. (2003). Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours. Med Pediatr Oncol 40, 224-229.
147. Stevens, G., Downes, S., and Ralston, A. (1998). Thyroid dose in children undergoing prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 42, 385-390.
148. Stewart, P.M., Corrie, J., Seckl, J.R., Edwards, C.R., and Padfield, P.L. (1988). A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1, 1208-1210.
149. Strandqvist, M. Studien über die kumulative Wirkung der Röntgenstrahlen bei Fraktionierung. Acta Radiol. 55 (Suppl.):1-300 (1944).
150. Streeten, D.H., Anderson, G.H.J., and Bonaventura, M.M. (1996). The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab 81, 285-290.
151. Syndikus, I., Tait, D., Ashley, S., and Jannoun, L. (1994). Long-term follow-up of young children with brain tumors after irradiation. Int.J.Radiat.Oncol.Biol.Phys. 30, 781-787.
152. Tait, D.M., Thornton-Jones, H., Bloom, H.J., Lemerle, J., and Morris-Jones, P. (1990). Adjuvant chemotherapy for medulloblastoma: the first multicentre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26, 464-469.
153. Tan, B.C. and Kunaratnam, N. (1966). Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma. Clin Radiol 17, 302-304.
154. Taylor, R.E., Bailey, C.C., Robinson, K., Weston, C.L., Ellison, D., Ironside, J., Lucraft, H., Gilbertson, R., Tait, D.M., Walker, D.A., Pizer, B.L., Imeson, J., and Lashford, L.S. (2003). Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 21, 1581-1591.
155. Tell, R., Sjodin, H., Lundell, G., Lewin, F., and Lewensohn, R. (1997). Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 39, 303-308.
156. Thaler, L.M. and Blevins, L.S.J. (1998). The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 83, 2726-2729.
157. Thames, H.D. and Hendry, J.H. (1987). Fractionation in Radiotherapy. First edition. Taylor and Francis, London. 53-99.
158. Tillmann, V., Buckler, J.M., Kibirige, M.S., Price, D.A., Shalet, S.M., Wales, J.K., Addison, M.G., Gill, M.S., Whatmore, A.J., and Clayton, P.E. (1997). Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 82, 531-535.
159. Tordjman, K., Jaffe, A., Trostanetsky, Y., Greenman, Y., Limor, R., and Stern, N. (2000). Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clin Endocrinol (Oxf) 52, 633-640.
160. Tsatsoulis, A., Shalet, S.M., Morris, I.D., and de Kretser, D.M. (1990). Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis. Horm Res 34, 254-259.
161. Van Santen, H.M., Vulsma, T., Dijkgraaf, M.G., Blumer, R.M., Heinen, R., Jaspers, M.W., Geenen, M.M., Offringa, M.O., de Vijlder, J.J., and van den Bos, C. (2003). No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 88, 3657-3663.
162. Van der Kogel,A.J.; Ruitfrok,A.C.C; Calculation of isoeffect relationships. (1999). Basic Clinical Radiobiology (Steel, G.G., Ed.) Second Edition edition. Edward Arnold Publishers, London. 72-79.
163. Wallace, E.M., Groome, N.P., Riley, S.C., Parker, A.C., and Wu, F.C. (1997). Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J Clin Endocrinol Metab 82, 3111-3115.
164. Watson, A.R., Rance, C.P., and Bain, J. (1985). Long term effects of cyclophosphamide on testicular function. Br Med J (Clin Res Ed) 291, 1457-1460.
165. Weintrob, N., Sprecher, E., Josefsberg, Z., Weininger, C., Aurbach-Klipper, Y., Lazard, D., Karp, M., and Pertzelan, A. (1998). Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies. J Clin Endocrinol Metab 83, 88-92.
166. Wheldon,T.E.; Deehan,C.; Wheldon,E.G; Barrett,A. (1997). The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. Radiotherapy and Oncology 46, 285-95.
167. Whitehead, E., Shalet, S.M., Jones, P.H., Beardwell, C.G., and Deakin, D.P. (1982). Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Arch Dis Child 57, 287-291.